Fermentative production of sialylated saccharides
AssigneeJennewein Biotechnologie GmbH
InventorsStefan JENNEWEIN, Dirk WARTENBERG
Life of this patent
Estimating the term…
Abstract
Disclosed are methods for the fermentative production of a sialylated saccharide and genetically engineered microbial cells for use in said method, wherein the genetically engineered microbial cells comprise (i) a sialic acid biosynthesis pathway comprising a glucosamine-6-phosphate N-acetyltransferase, (ii) a cytidine 5′-monophospho-(CMP)-N-acetylneuraminic acid synthetase; and (iii) a sialyltransferase, for producing sialylated saccharides, as well as the use of said sialylated oligosaccharides for providing nutritional compositions.
Claims15
A method for fermentative production of a saccharide comprising at least one N-acetylneuraminic acid moiety, the method comprising
- a) providing at least one genetically engineered microbial cell which comprises
- (i) a sialic acid biosynthesis pathway comprising a glucosamine-6-phosphate N-acetyltransferase;
- (ii) a cytidine 5′-monophospho-(CMP)-N-acetylneuraminic acid synthetase;
- and
- (iii) a heterologous sialyltransferase;
- b) cultivating the at least one genetically-engineered microbial cell in a fermentation broth and under conditions permissive for production of said saccharide comprising at least one N-acetylneuraminic acid moiety;
- and optionally
- c) recovering said saccharide comprising at least one N-acetylneuraminic acid moiety.
A genetically-engineered microbial cell for fermentative production of a saccharide comprising at least one N-acetylneuraminic acid moiety, wherein the genetically-engineered microbial cell comprises
- (i) a synthetic sialic acid biosynthesis pathway comprising a glucosamine-6-phosphate N-acetyltransferase;
- (ii) a cytidine 5′-monophospho-(CMP)-N-acetylneuraminic acid synthetase;
- and
- (iii) a heterologous sialyltransferase.
Dependencies are inferred from the claim text.